Form 4: Mustang Bio Insider Sells Shares for Tax Cover

Mustang Bio's President, CEO, and Interim CFO, Manuel Litchman, reported a transaction involving the relinquishment of 19 common shares to cover tax liabilities.

Summary

• Manuel Litchman, President, CEO, and Interim CFO of Mustang Bio, Inc., reported a transaction on April 24, 2026.
• The transaction involved the relinquishment of 19 shares of common stock.
• These shares were used to cover tax liabilities arising from the vesting of restricted stock units.
• Following this transaction, Litchman beneficially owns 1,615 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a standard reporting event for covering tax liabilities upon stock vesting and does not indicate a significant change in the executive's overall stake or sentiment towards the company.

Negatives

• The company's executive is selling shares, even if for tax cover, which can sometimes be perceived negatively by the market.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Management Comments

• 19 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions, such as this one by Mustang Bio's CEO, which often relate to stock vesting and associated tax obligations. These filings provide transparency into executive compensation and potential insider selling or buying activity.

Stakeholder Impact

• Shareholders: The transaction is a routine event for covering tax liabilities and does not inherently signal a change in the executive's long-term commitment to the company. However, any insider selling can be a point of observation for investors.

Key Dates

Keywords

SEC Form 4, Insider Transaction, Mustang Bio, MBIO, Stock Vesting, Tax Liability, Beneficial Ownership